Elsevier

Seizure

Volume 23, Issue 5, May 2014, Pages 344-348
Seizure

Clinical heterogeneity of juvenile myoclonic epilepsy: Follow-up after an interval of more than 20 years

https://doi.org/10.1016/j.seizure.2014.01.012Get rights and content
Under an Elsevier user license
open archive

Abstract

Purpose

The view that juvenile myoclonic epilepsy (JME) is a uniform and life-long disorder is currently being challenged. The aim of this study was to assess the seizure and psychosocial outcome of JME at least 20 years after onset.

Methods

In 1992, 42 patients with JME were identified. In 2012, 37 agreed to a semi-structured interview. In the remaining five, only medical records were available.

Results

Of 40 patients with known seizure outcome, 21 were in remission for >5 years. Seven were off antiepileptic drugs (AEDs), four being seizure free for >10 years. Myoclonic seizures (MC) evolving to generalized tonic–clonic seizures (GTC) were associated with seizure persistence (p = 0.013), whereas >1 year between MC and GTC onset was associated with a trend to GTC remission (p = 0.069). Of 19 patients with uncontrolled seizures, eight experienced remission with second generation AEDs.

Favorable psychosocial outcome by interview was found in a third, whereas another third had psychiatric comorbidity, seven with substance or alcohol abuse. Psychosocial and seizure outcome did not correlate.

Conclusion

This study corroborates the heterogeneity of JME in terms of seizure and psychosocial outcome, but without a clear association between the two. It confirms that seizure control may persist after AED withdrawal in some and supports MC evolving to GTC as a predictor of seizure persistence. Moreover, it suggests that newer broad spectrum AEDs may improve the prognosis of JME; their impact should be focus of prospective studies.

Keywords

Juvenile myoclonic epilepsy
Long-term follow-up
Seizure outcome
Psychosocial outcome

Cited by (0)

1

These authors contributed equally and are joint second authors.